ASPS Addresses Concerns Regarding BOTOX Treatments
Jan 29th 2008Drug InformationCosmetic Medicine
The American Society of Plastic Surgeons (ASPS) addressed concerns regarding the use of botulinum toxin products and adverse events following a recent petition from a consumer group. On January 23, Public Citizen requested the U.S. Food and Drug Administration (FDA) implement labeling changes and a written communication to physicians. More than one million people have been treated with BOTOX Cosmetic.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
